Effects of hypoxia on drug resistance phenotype and genotype in human glioma cell lines (original) (raw)

References

  1. Walker AE, Robins M, Weinfeld FD: Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology 35:219–226,1985
    Google Scholar
  2. Walker MD, Green SB, Byar DP, Alexander E, Betzdorf U, Brooks WH, Hunt WE, MacCarty M: Randomized comparisons of radiotherapy and nitrosureas for the treatment of malignant gliomas after surgery. New Eng J Med303:1323–1329, 1980
    Google Scholar
  3. Feun LG, Savaraj N, Landy H: Drug resistance in brain tumors. J Neurone 20:165–176,1994
    Google Scholar
  4. Endicott JA, Ling V: The biochemistry of P-Glycoproteinmediated multidrug resistance. Annu Rev Biochem 58:137–171, 1989
    Article CAS PubMed Google Scholar
  5. Cole SPC, Nhardaj C, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV, Deeley RG: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650–1654, 1992
    CAS PubMed Google Scholar
  6. Rosenblum ML, Gerosa MA, Bodell WJ, Talcott RL: Tumor cell resistance. In: Progress in Experimental Research, Volume 27, pp 191–211. Karger Publishers, Basel, 1984
    Google Scholar
  7. Dabholkar M, Vionnet J, Bostick-Bruton F, Yu JJ, Reed E: Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate to response to platinum based chemotherapy. J Clin Invest 94:703–708,1994
    Google Scholar
  8. Dabholkar M, Bostick-Bruton R, Reed E: ERCC1 and ERCC2 expression in fresh human tumor tissues. J Natl Cancer Inst 84:1512–1517,1992
    Google Scholar
  9. Teicher BA: Hypoxia and drug resistance. Cane Metas Rev 13:139–168,1994
    Google Scholar
  10. Shapiro WR, Shapiro JR: Principles of brain tumor chemotherapy. Semin Oncol 13:56–69,1986
    Google Scholar
  11. Teicher BA, Waxman DJ, Holden SA, Wang Y, Clarke L, Alvarez Sotomayor E, Jones SM, Frei E: Evidence for enzymatic activation and oxygen involvement in cytotoxicity and antitumor activity of N, N′, N″-triethylenethiophosphoramide. Cancer Res 49:4996–5001,1989
    Google Scholar
  12. Rice GC, Ling V, Shimke RT: Frequencies of independent and simultaneous selection of Chinese hamster cells for methotrexate and doxorubicin (adriamycin) resistance. Proc Natl Acad Sci 84:9261–9264,1987
    CAS PubMed Google Scholar
  13. Schlappack OK, Zimmermann A, Hill RP: Glucose starvation and acidosis: effect on experimental metastatic potential, DNA content and MTX resistance of murine tumor cells. Br J Cancer 64:663–670,1991
    Google Scholar
  14. Wilson RE, Keng PC, Sutherland RM: Drug resistance in Chinese hamster ovary cells during recovery from severe hypoxia. J Nall Cancer Inst 81:1235–1240,1989
    Google Scholar
  15. Wilson RE, Talley RD, Storch TG:Oxygen concentration regulated EGF-induced proliferation and EGFR down regulation. Biochim Biophys Res Commun 153: 952–958, 1988
    Google Scholar
  16. Deguchi Y, Negoro S, Kishimoto S: c-fos expression in human skin fibroblasts by reperfusion after oxygen deficiency: a recovery change of human skin fibroblasts after oxygen deficiency stress. Biochim Biophys Res Commun 149:1093–1098, 1987
    Google Scholar
  17. Young SD, Hill RP: Effects of reoxygenation of cells from hypoxic regions of solid tumors: anticancer drug sensitivity and metastatic potential. J Natl Cancer Inst 82:371–380, 1990
    Google Scholar
  18. Rice GC, Hoy C, Schimke RT: Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc Natl Acad Sci 83:5978–5982, 1986
    CAS PubMed Google Scholar
  19. Nakatsu Y, Hattori K, Hayakawa H, Shimizu K, Sekiguchi M:Organization and expression of the human gene for 06, m-methylguanine-DNA methyltransferase. Mut Res 293: 119–132,1993
    Google Scholar
  20. Heacock CS, Sutherland RM: Enhanced synthesis of stress proteins caused by hypoxia and relation to altered cell growth and metabolism. Br J Cancer 62:217–225,1990
    Google Scholar
  21. Sciandra JJ, Subjeck JR, Hughes CS: Induction of glucoseregulated proteins during anaerobic exposure and of heatshock proteins after reoxygenation. Proc Natl Acad Sci 81: 4843–4847,1984
    Google Scholar
  22. Brown JM, Giaccia AJ: Tumor hypoxia: the picture has changed in the 1990s. Int J Radiat Biol 65:95–102,1994
    Google Scholar
  23. Yao KS, Clayton M, O'Dwyer PJ: Interaction of head and hypoxia modulating transcription of DT diaphorase in human colon adenocarcinoma cells. Cell Growth Differ 5:125–131, 1994
    Google Scholar
  24. Shapiro WR: Therapy of adult malignant brain tumors: What have the clinical trials taught us? Semin Oncol 13:38–45, 1986
    Google Scholar
  25. Nyce J: Drug-induced DNA hypermethylation and drug resistance in human tumors. Cane Res 49:5829–5836,1989
    Google Scholar
  26. Bentivegna SS, Bresnick E: Inhibition of human 06-methylguanine-DNA methyltransferase by 5-methylcytosine. Cane Res 54:327–329,1994
    Google Scholar
  27. Sakata K, Tak Kwok T, Murphy BJ, Laderoute KR, Gordon GR, Sutherland RM: Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance. Br J Cancer 64:809–814,1991
    Google Scholar
  28. Bodell WJ, Tokuda K, Ludlum DB: Differences in DNA alkylation products formed in sensitive and resistant human glioma cells treated with N-(2-chloroethyl)-1-nitrosurea. Cane Res 48:4489–4492,1988
    Google Scholar
  29. Hill DL, Kirk MC, Struck RF: Microsomal metabolism of nitrosureas. Cane Res 35:296–301,1975
    Google Scholar
  30. Hill DL, N,N′-bis(2-chloroethyl)-N-nitrosurea, a substrate for glutathione (GSH) S-transferase. Proc Am Assoc Cane Res 17:52,1976
    Google Scholar
  31. Talcott RE, Levin VA: Glutathione-dependent denitrosation of BCNU: Nitrite release catalyzed by mouse liver cytosol in vitro. Drug Metab Disappos 11:175–176,1983
    Google Scholar
  32. Smith MT, Evans CG, Doane-Setzar P, Castro VM, Tahir MK, Mannervik B: Dentrosation of 1, 3-bis(2-chloroethyl) 1-nitrosurea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells. Cane Res 49: 2621–2625,1989
    Google Scholar
  33. Montaudon D, Bencherkroun MN, Londos-Gagliardi D, Robert J: Chromosomal modifications of a rat glioblastoma cell line during the acquisition and reversal of doxorubicin resistance. Anticanc Res 10:1667–1676,1990
    Google Scholar
  34. Liang BC, Ross DA, Reed E: Genomic copy number changes of DNA repair genes ERCCI and ERCC2 in human gliomas. J Neuroonc, 26:17–231995
    Google Scholar
  35. Matsumoto T, Tani E, Kaba K, Kochi N, Shindo H, Miyaji K: Amplification and expression of a multidrug resistance gene in human glioma cell line. J Neurosurg 72:96–101,1990
    Google Scholar
  36. Nabors MW, Griffin CA, Zehnbauer BA, Hruban RH, Phillips PC, Grossman SA, Brem H, Colvin OM: Multdrug resistance gene (MDR1) expression in human brain tumors. J Neurosurg 75:941–946, 1991
    Google Scholar
  37. Abe T, Hasegawa S, Taniguchi K, Yokomizo A, Kuwano T, Ono M, Mori T, Hori S, Kohno K, Kuwano M: Possible involvement of multidrug-resistance associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide, and adriamycin in human glioma cells. Int J Cane 58:860–864,1994
    Google Scholar
  38. Simon S, Roy D, Shindler M: Intracellular pH and the control of multidrug resistance. Proc Natl Acad Sci 91:1128–1132, 1994
    Google Scholar
  39. Schneider E, Aftenberg GA, Cowen K: Increased intracellular pH as a possible mechanism of MRP-mediated mul tidrug resistance in the human mammary carcinoma cell line MCF7/VP. Proc Am Assoc Cane Res 36:325,1995
    Google Scholar
  40. Bougnoux P, Chajes V, Hubert B, Germain E, Lhuillery C, Saez S, Calais G: n-3 polyunsaturated fatty acids and chemosensitivity of breast carcinoma. Proc Am Assoc Cane Res 36:327,1995
    Google Scholar
  41. Owen R, Andrews PA, Murphy MP: Significant differences in DNA-binding proteins purified from MCF-7 adriamycin resistant versus sensitive breast carcinoma cell lines. Proc Am Assoc Cane Res 36:327,1995
    Google Scholar

Download references